Mcl-1 expression is a predictive marker of response to gemcitabine plus nab-paclitaxel for metastatic pancreatic cancer
Makiko Urabe(Osaka International Cancer Institute), Kazuyoshi Ohkawa(Osaka International Cancer Institute)
Cited by 2
Related Papers
No related papers found
Powered by citation graph analysis